As we look back, our news highlights during the pandemic year of 2020 spotlight how we joined together to overcome challenges to carry on with our mission to find cures for chronic neurological disabilities.
Benfotiamine and Cognitive Decline in Alzheimer's Disease, a small exploratory clinical trial, conducted by Dr. Gary E. Gibson’s laboratory at the Burke Neurological Institute is listed in CNN Health’s article on ”Top 2020 health stories you may have missed because of Covid-19” under Advances in Alzheimer’s.
A small exploratory clinical trial conducted by Dr. Gary E. Gibson’s laboratory at the Burke Neurological Institute in collaboration with physicians at the Burke Rehabilitation Hospital, suggests that Benfotiamine is safe and potentially efficacious in improving cognitive outcomes among people living with Mild Cognitive Impairment and mild Alzheimer’s disease (AD).
On Wednesday, November 18, 2020, Dr. Dianna Willis spoke about life of a scientist to children of the Kliptown Youth Program in South Africa, an educational program that helps boost academic excellence among very disadvantaged children.
